Colleen Acosta, Freya Biosciences CEO
December 12, 2023 07:00 AM ESTUpdated 12:55 PM
Financing
Startups

Ex­clu­sive: Women’s health biotech Freya Bio­sciences rais­es $38M for mi­cro­bial im­munother­a­pies

Kyle LaHucik

Senior Reporter

Freya Bio­sciences, a Dan­ish and US biotech named af­ter the Norse god­dess of fer­til­i­ty, has raised a $38 mil­lion Se­ries A, the clin­i­cal-stage start­up told …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

A service from the Financial Times